Unofficial Translation
Approved by the Federal Government on October 20, 2016
World Aids Day, 1. December 2018
Commemorating 30 Years
Accessed: 05.10.2019
HIV testing
Policy Brief
July 2015
Accelerating HIV prevention to reduce new infections by 75%
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...duce HIV-related morbidity and mortality. Further, co-trimoxazole is an off-patent drug and widely available in resource-limited settings.
more
PLoS Pathogens | www.plospathogens.org 1
February 2012 | Volume 8 | Issue 2 | e100246
Health and Human Rights Journal
December 2016 / Volume 18 / Number 2 / Papers, 171-182
This study aimed to understand the patterns of HIV drug resistance in pregnant women in Mozambique. This might help in tailoring optimal regimens for prevention of mother to child transmission of HIV (pMTCT) and antenatal care.
Policy Brief, Updated in March 2017
A regional consultation report and draft transition framework
Tokar A, et al. Sex Transm Infect 2019;95:193–200. doi:10.1136/sextrans-2018-053684
Bull World Health Organ 2015;93:457–467 | doi: http://dx.doi.org/10.2471/BLT.14.147215
HIV Treatment
Policy Brief
July 2017